Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
TGF-β-activated kinase 1 (TAK1) is a member of the serine/threonine MAP3K family that has roles in immunity and inflammation.1,2 It binds to TAK1-binding protein 1 (TAB1) at its N-terminal kinase domain and to TAB2 and TAB3 at its C-terminal domain.1 TAK1 is ubiquitously expressed and constitutively associated with its activating binding partner TAB1, whereas it only associates with TAB2 and TAB3 following stimulation by upstream factors such as IL-1β.3,4,5,2 It is involved in innate and adaptive immunity and the inflammatory response.1,2 A TAK1-TAB1 fusion protein induces the activation of JNK, p38 MAPK, and IĸB kinase (IKK) and the production of IL-6 in cancer cells.5 Tak1 knockdown induces splenomegaly and increases serum levels of several interleukin cytokines in mice.6 Hyperactivation of TAK1-TAB complexes is associated with autoimmune diseases and tumorigenesis.2 Cayman’s TAK1-TAB1 Fusion (human, recombinant) protein can be used for enzyme activity assays.
WARNING This product is not for human or veterinary use.
1. TAK1, more than just innate immunity. IUBMB Life 64(10), 825-834 (2012).
2. TAK1-
3. Molecular cloning of human TAK1 and its mutational analysis in human lung cancer. Int. J. Cancer 75(4), 559-563 (1998).
4. TAK1 mitogen-
5. TAK1-
6. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS One 8(3), e57348 (2013).